Work

Small Cell Lung Cancer: New Hope, New Challenges

Year: 2024

Type: editorial

Abstract: This commentary focuses on the exciting, unprecedented FDA accelerated approval of Tarlatamab in SCLC and highlights potential challenges that will be faced by Oncology community in integrating such I

Source: JCO oncology advances.

DOI: 10.1200/oa.0000000000000001

Authors: Parth Desai, Anish Thomas

Institutions: Fox Chase Cancer Center, Temple University Hospital, National Institutes of Health, National Cancer Institute

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4402515834

Cites: 15

Cited by: 8

Related to: 10